Literature DB >> 7002977

Physical urticaria/angioedema: an experimental model of mast cell activation in humans.

N A Soter, S I Wasserman.   

Abstract

Urticaria and angioedema may occur in skin and mucus membranes when mast cells are activated by various physical stimuli, including trauma, pressure, vibration, light, cold, heat, and (in rare cases) water. Experimental challenge of patients with cold-induced and cholinergic urticaria/angioedema in particular provides an in vivo model of mast cell activation in humans. This model synthesizes observations of the evolution of clinical manifestations, histologic analysis of tissue alterations, measurement of mediators released into the circulation, and assessment of leukocyte motility. The model in turn allows a characterization of mediators that exist preformed in mast cell granules or that are generated through interactions with other cell types. Release of these mediators produces a variety of biologic effects, including elaboration of certain enzymes and alterations in venular permeability, smooth muscle contraction, leukocyte motility, and the release of substances from other cell types.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002977     DOI: 10.1016/0091-6749(80)90114-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  What is "inflammation"? Are we ready to move beyond Celsus?

Authors:  A Scott; K M Khan; J L Cook; V Duronio
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

Review 2.  Review of Physical Urticarias and Testing Methods.

Authors:  Mario Sánchez-Borges; Luis González-Aveledo; Fernan Caballero-Fonseca; Arnaldo Capriles-Hulett
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

3.  Allergy-epitomes of progress: physical urticarias: an important cause of hives.

Authors:  J R Tencati
Journal:  West J Med       Date:  1981-07

Review 4.  Urticaria and angioedema.

Authors:  B A Burrall; A C Huntley
Journal:  Clin Rev Allergy       Date:  1985-02

Review 5.  Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management.

Authors:  Atsushi Fukunaga; Ken Washio; Mayumi Hatakeyama; Yoshiko Oda; Kanako Ogura; Tatsuya Horikawa; Chikako Nishigori
Journal:  Clin Auton Res       Date:  2017-04-05       Impact factor: 4.435

Review 6.  New concepts of hive formation in cholinergic urticaria.

Authors:  Tastuya Horikawa; Atsushi Fukunaga; Chikako Nishigori
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 7.  Chronic urticaria.

Authors:  B A Burrall; G M Halpern; A C Huntley
Journal:  West J Med       Date:  1990-03

Review 8.  Cholinergic Urticaria: Subtype Classification and Clinical Approach.

Authors:  Atsushi Fukunaga; Yoshiko Oda; Shinya Imamura; Mayuko Mizuno; Takeshi Fukumoto; Ken Washio
Journal:  Am J Clin Dermatol       Date:  2022-09-15       Impact factor: 6.233

9.  Evaluation of different combined regimens in the treatment of cholinergic urticaria.

Authors:  Abdulghani M Alsamarai; Ali A Hasan; Amina H Alobaidi
Journal:  World Allergy Organ J       Date:  2012-08       Impact factor: 4.084

10.  A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells.

Authors:  Alexander J Stokes; Lori M N Shimoda; Murielle Koblan-Huberson; Chaker N Adra; Helen Turner
Journal:  J Exp Med       Date:  2004-07-12       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.